The poster presented in Vienna by the Pr. Frédéric Laurent’s team (National Reference Center for Staphylococci) show that the MOLSID biotracer has demonstrated 100% sensitivity and specificity for the detection of BlaZ, both in S. aureus and in other staphylococcal species encountered in clinical practice.
This is the only reliable phenotypic test available on the market that can solve any ambiguity regarding the presence of active penicillinase in methicillin-sensitive staphylococci, in addition to the antibiogram.
Recent posts
It was a pleasure for MOLSID, represented by its Executive Director Younes Lazrak, to present our product pipeline at this year’s ESCMID GLOBAL. Many thanks
A new fundraising round has been opened and will close in Q1 2024, with existing and new investors. This round will allow us to speed
We have updated our corporate clip. Have a look to learn more about who we are and what we do!
